Additional research has verified that COMMD10 may enhance copper synthesis during ionising radiation (IR), resulting in resistance to radiotherapy (Yang M. et al., 2022), so presenting a novel therapeutic target for augmenting the sensitivity of HCC to radiotherapy. Here, COMMD10 is linked to hepatocellular carcinoma.